Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 93: | Line 93: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+/- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+ | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
|<nowiki>+</nowiki> | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 246: | Line 246: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-/+</nowiki> | |<nowiki>-/+</nowiki> | ||
* Intermittent | |||
* Secretory type | |||
| <nowiki>+</nowiki> | | <nowiki>+</nowiki> | ||
| <nowiki>-</nowiki> | | <nowiki>-</nowiki> | ||
Line 274: | Line 276: | ||
peri-appendiceal inflammation, fluid accumulation,fat stranding | peri-appendiceal inflammation, fluid accumulation,fat stranding | ||
|Increased fluid signal on | |Increased fluid signal on T2 weighted sequence | ||
|Evidences of [[inflammation]] | |Evidences of [[inflammation]] | ||
|[[Tc-99m]] labeled anti-[[CD15]] [[antibodies]] | |[[Tc-99m]] labeled anti-[[CD15]] [[antibodies]] |
Revision as of 18:17, 8 February 2019
Appendix cancer Microchapters |
Diagnosis |
---|
Treatment |
Appendix cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Appendix cancer differential diagnosis |
Risk calculators and risk factors for Appendix cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
appendix cancer must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
appendix cancer must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating appendix cancer from other Diseases
appendix cancer must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
appendix cancer must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating appendix cancer from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], appendix cancer must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||||||||||
Abdominal pain | Change in girdle size | Change in bowel habits | Flushing | Palpitation | Dyspnea | Other symptoms | Abdominal mass | abdominal tenderness | Wheezing | Tricuspid regurgitation murmur | Urinary 5-hydroxyindoleacetic acid (5-HIAA) | Serum Chromogranin A (CgA) | Other lab findings | CT scan | MRI | Utrasounography | Other imaging modalities | |||||||
Diarrhea | Constipation | |||||||||||||||||||||||
Appendix cancer | Adenocarcinoma | |||||||||||||||||||||||
Carcinoid tumor | +/- | - | + | - | + | + | + | - | - | + | + | + | + | |||||||||||
Mucocele | ||||||||||||||||||||||||
Ovarian tumor | ||||||||||||||||||||||||
Pseudomyxoma peritonei | ||||||||||||||||||||||||
Carcinoid syndrome | ||||||||||||||||||||||||
Appendicitis | LLQ / RRQ | - | -/+
|
+ | - | -/+
Tachycardia is prevalent |
- | Nausea & vomiting,decreased appetite
Anorexia |
+/- | + | - | - |
, |
- | - |
|
Appendiceal wall thickening /perforation
peri-appendiceal inflammation, fluid accumulation,fat stranding |
Increased fluid signal on T2 weighted sequence | Evidences of inflammation | Tc-99m labeled anti-CD15 antibodies | Evidences of inflammation | CT scan | Alvarado Score | |
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings | |||||||||
Differential Diagnosis 4 | ||||||||||||||||||||||||
Differential Diagnosis 5 | ||||||||||||||||||||||||
Differential Diagnosis 6 |